Report cover image

Preclinical Imaging Market

Publisher Grand View Research
Published Jan 07, 2026
Length 120 Pages
SKU # GV20873119

Description

Preclinical Imaging Market Summary

The global preclinical imaging market size was valued at USD 1.05 billion in 2025 and is expected to reach USD 1.63 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. This growth is driven by the rising prevalence of chronic diseases, increasing investments in drug development, and growing demand for non-invasive imaging techniques.

The adoption of advanced imaging modalities for early-stage research, coupled with the expansion of translational research initiatives, further accelerates market expansion.

Government initiatives, including grants and funding from organizations such as the National Institutes of Health (NIH) and similar agencies in Europe and Asia, are significantly enhancing preclinical research and bolstering the preclinical imaging market. For example, in September 2022, the NIH and the U.S. Department of Health and Human Services (DHHS) called for applications for milestone-driven preclinical vaccine development targeting Enterotoxigenic Escherichia coli (ETEC), Salmonella Paratyphi A, and Shigella species.

The program supported vaccine optimization, scale-up, safety, and efficacy testing, offering up to USD 750,000 annually over five years to help candidates reach clinical readiness. Eligible applicants included academic institutions, nonprofits, governments, and businesses. The National Institute of Allergy and Infectious Diseases (NIAID) planned to award USD 5.2 million across 4-6 projects to advance candidates toward FDA IND submission. This influx of funding allows researchers to invest in advanced platforms, develop new probes, and expand longitudinal studies, increasing demand in the preclinical in-vivo imaging market and supporting growth in segments like optical preclinical imaging.

Global Preclinical Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global preclinical imaging market based on type, application, end use and region:
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Modality
  • Optical Imaging (BLI & F)
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Computed Tomography (CT)
  • Ultrasound Imaging (US)
  • Photoacoustic Imaging (PAI)
  • Hybrid Imaging Systems
  • Bi-Modal
  • SPECT-CT
  • PET-CT
  • SPECT-PET
  • PET-MRI
  • Optical-CT
  • Others
  • Tri-Modal
  • PET-SPECT-CT
  • PET-SPECT-MRI
  • PET-CT-Optical
  • Others
  • Others
  • Reagent
  • Service
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Toxicology & Pharmacokinetics Studies
  • Basic & Translational Research
  • Disease Mechanism & Pathophysiology Studies
  • Oncology
  • Cardiology
  • Neurology
  • Infectious Diseases
  • Immunology & Inflammation
  • Others
  • Biomarker & Imaging Agent Validation
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Third Party Perspective
1.3.5. Primary research
1.3.6. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Data Sources
1.8. List of Primary Sources
1.9. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Catheter Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Increasing number of clinical trials
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing Incidence of Chronic Disorders
3.3.1.2. Increasing Awareness of Controlling Catheter-Related Bloodstream Infections (CRBSI)
3.3.1.3. Growing Use of Advanced Materials in Catheters
3.3.2. Market Restraint Analysis
3.3.2.1. Stringent Regulations for Novel Product Launch
3.3.2.2. Risk and Complications Associated with the Catheters
3.3.3. Market Opportunities Analysis
3.3.3.1. Growing Preference for Minimally Invasive Procedures
3.3.4. Market Challenge Analysis
3.3.4.1. High Cost of Products
3.4. Catheter Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Bargaining power of suppliers
3.4.1.2. Bargaining power of buyers
3.4.1.3. Threat of substitutes
3.4.1.4. Threat of new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political & Legal Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological landscape
Chapter 4. Catheter Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Product Market Share, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Catheter Market Movement Analysis
4.5. Catheter Market: Product Movement Analysis & Market Share, 2025 & 2033
4.6. Cardiovascular Catheters
4.6.1. Cardiovascular Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.1.1. Electrophysiology Catheters
4.6.1.1.1. Electrophysiology Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.6.1.2. PTCA Balloon Catheters
4.6.1.2.1. PTCA Balloon Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.6.1.3. IVUS Catheters
4.6.1.3.1. IVUS Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.6.1.4. PTA Balloon Catheters
4.6.1.4.1. PTA Balloon Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.7. Urology Catheters
4.7.1. Urology Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.7.1.1. Hemodialysis Catheters
4.7.1.1.1. Hemodialysis Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.7.1.2. Peritoneal Catheters
4.7.1.2.1. Peritoneal Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.7.1.3. Foley Catheters
4.7.1.3.1. Foley Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.7.1.4. Intermittent Catheters
4.7.1.4.1. Intermittent Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.7.1.5. External Catheters
4.7.1.5.1. External Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.8. Intravenous Catheters
4.8.1. Intravenous Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.8.1.1. Peripheral Catheters
4.8.1.1.1. Peripheral Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.8.1.2. Midline Peripheral Catheters
4.8.1.2.1. Midline Peripheral Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.8.1.3. Central Venous Catheters
4.8.1.3.1. Central Venous Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.9. Neurovascular Catheters
4.9.1. Neurovascular Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.10. Specialty Catheters
4.10.1. Specialty Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.10.1.1. Wound/Surgical Catheters
4.10.1.1.1. Wound/Surgical Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.10.1.2. Oximetry Catheters
4.10.1.2.1. Oximetry Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.10.1.3. Thermodilution Catheters
4.10.1.3.1. Thermodilution Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
4.10.1.4. IUI Catheters
4.10.1.4.1. IUI Catheters Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
Chapter 5. Catheter Market: End Use Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. End Use Market Share, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Catheter Market Movement Analysis
5.5. Catheter Market: End Use Movement Analysis & Market Share, 2025 & 2033
5.6. Hospital Stores
5.6.1. Hospital Stores Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
5.7. Retail Stores
5.7.1. Retail Stores Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
Chapter 6. Catheter Market: Regional Estimates & Trend Analysis, By End Use, By Product
6.1. Regional Outlook
6.2. Catheter Market: Regional Movement Analysis & Market Share, 2025 & 2033
6.3. North America
6.3.1. North America Catheter Market Estimates and Forecasts, 2021 – 2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Scenario
6.3.2.4. Reimbursement Scenario
6.3.2.5. U.S. Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Scenario
6.3.3.4. Reimbursement Scenario
6.3.3.5. Canada Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Scenario
6.3.4.4. Reimbursement Scenario
6.3.4.5. Mexico Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Europe
6.4.1. Europe Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Scenario
6.4.2.4. Reimbursement Scenario
6.4.2.5. UK Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Scenario
6.4.3.4. Reimbursement Scenario
6.4.3.5. Germany Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Scenario
6.4.4.4. Reimbursement Scenario
6.4.4.5. France Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Scenario
6.4.5.4. Reimbursement Scenario
6.4.5.5. Italy Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Scenario
6.4.6.4. Reimbursement Scenario
6.4.6.5. Spain Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Scenario
6.4.7.4. Reimbursement Scenario
6.4.7.5. Denmark Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Scenario
6.4.8.4. Reimbursement Scenario
6.4.8.5. Sweden Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Scenario
6.4.9.4. Reimbursement Scenario
6.4.9.5. Norway Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Scenario
6.5.2.4. Reimbursement Scenario
6.5.2.5. Japan Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Scenario
6.5.3.4. Reimbursement Scenario
6.5.3.5. China Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Scenario
6.5.4.4. Reimbursement Scenario
6.5.4.5. India Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Scenario
6.5.5.4. Reimbursement Scenario
6.5.5.5. South Korea Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Scenario
6.5.6.4. Reimbursement Scenario
6.5.6.5. Australia Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Scenario
6.5.7.4. Reimbursement Scenario
6.5.7.5. Thailand Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Scenario
6.6.2.4. Reimbursement Scenario
6.6.2.5. Brazil Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Scenario
6.6.3.4. Reimbursement Scenario
6.6.3.5. Argentina Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Middle East & Africa
6.7.1. Middle East & Africa Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Scenario
6.7.2.4. Reimbursement Scenario
6.7.2.5. South Africa Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Scenario
6.7.3.4. Reimbursement Scenario
6.7.3.5. Saudi Arabia Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Scenario
6.7.4.4. Reimbursement Scenario
6.7.4.5. UAE Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Scenario
6.7.5.4. Reimbursement Scenario
6.7.5.5. Kuwait Catheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2025
7.3.4. Boston Scientific Corporation
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Teleflex Incorporated
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Medtronic
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Hollister Incorporated
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Edward Lifesciences
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Smith Medical Inc.
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. ConvaTec Group Plc
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Cure Medical LLC
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. BD
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Cook Medical Inc.
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Terumo Corporation
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.4. Heat Map Analysis/ Company Market Position Analysis
7.5. Estimated Company Market Share Analysis, 2024
7.6. List of Other Key Market Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us